The United States Food and Drug Administration (FDA) plays a critical role in protecting the U.S. from chemical, biological, radiological, nuclear (CBRN), and emerging infectious disease threats such as pandemic influenza and Zika virus. FDA is responsible for reviewing the safety and effectiveness of medical countermeasures (MCMs)—including drugs, therapeutic biologics, vaccines, and devices, such as diagnostic tests—to counter these threats. This is the FDA’s fiscal year 2018 report detailing its MCM activities.
https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/UCM635548.pdf
